ECM
ALPN

ExodusPoint Capital Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

ExodusPoint Capital Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-171,251
Closed -$6.79M – 2105
2024
Q1 		$6.79M Sell
171,251
-37,723
-18% -$1.11M 0.05% 305
2023
Q4 		$3.98M Sell
208,974
-8,081
-4% -$112K 0.03% 392
2023
Q3 		$2.48M Buy
217,055
+154,216
+245% +$1.9M 0.02% 612
2023
Q2 		$646K Buy
+62,839
New +$567K 0.01% 1265
2021
Q2 		– Sell
-36,359
Closed -$385K – 2928
2021
Q1 		$385K Sell
36,359
-53,870
-60% -$672K 0.01% 1519
2020
Q4 		$1.14M Buy
+90,229
New +$886K 0.01% 791

ExodusPoint Capital Management's ALPN Position: Q2 2024 in Review

ExodusPoint Capital Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 171,251 shares — an estimated $6.79M sold.

ExodusPoint Capital Management first reported a position in ALPN in Q4 2020 and held it in 6 quarters. The position peaked at $6.79M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • ExodusPoint Capital Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • ExodusPoint Capital Management sold 171,251 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $6.79M.
  • ExodusPoint Capital Management first reported a position in Alpine Immune Sciences Inc in Q4 2020 and held it in 6 quarters.
  • ExodusPoint Capital Management's Alpine Immune Sciences Inc position peaked at $6.79M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on ExodusPoint Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.